Shawn D. Keil

1.8k total citations
24 papers, 1.3k citations indexed

About

Shawn D. Keil is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Management of Technology and Innovation. According to data from OpenAlex, Shawn D. Keil has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 9 papers in Epidemiology and 6 papers in Management of Technology and Innovation. Recurrent topics in Shawn D. Keil's work include Mosquito-borne diseases and control (7 papers), Blood donation and transfusion practices (6 papers) and Blood transfusion and management (6 papers). Shawn D. Keil is often cited by papers focused on Mosquito-borne diseases and control (7 papers), Blood donation and transfusion practices (6 papers) and Blood transfusion and management (6 papers). Shawn D. Keil collaborates with scholars based in United States, Germany and Australia. Shawn D. Keil's co-authors include Raymond P. Goodrich, Patrick H. Ruane, Susanne Marschner, Richard A. Bowen, Heather L. Reddy, Jean‐Luc Ravanat, Matthew S. Platz, Jean Cadet, Christopher Martin and Laura Tonnetti and has published in prestigious journals such as RSC Advances, Transplantation and Photochemistry and Photobiology.

In The Last Decade

Shawn D. Keil

24 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shawn D. Keil United States 20 458 352 318 248 211 24 1.3k
Ute Gravemann Germany 15 232 0.5× 173 0.5× 141 0.4× 235 0.9× 91 0.4× 39 805
L. Lin United States 15 426 0.9× 267 0.8× 321 1.0× 69 0.3× 43 0.2× 23 738
Germán F. Leparc United States 17 149 0.3× 123 0.3× 149 0.5× 96 0.4× 70 0.3× 43 709
Shauna N. Hay United States 15 462 1.0× 260 0.7× 327 1.0× 58 0.2× 35 0.2× 30 883
Carl McDonald United Kingdom 19 531 1.2× 369 1.0× 262 0.8× 109 0.4× 58 0.3× 48 911
Peter A. Tomasulo United States 13 183 0.4× 187 0.5× 110 0.3× 118 0.5× 148 0.7× 21 952
Ross J. Molinaro United States 21 190 0.4× 24 0.1× 214 0.7× 68 0.3× 46 0.2× 53 1.5k
Leylagül Kaynar Türkiye 20 57 0.1× 38 0.1× 423 1.3× 218 0.9× 159 0.8× 160 1.4k
William Pollack United States 18 107 0.2× 21 0.1× 685 2.2× 116 0.5× 44 0.2× 55 1.3k

Countries citing papers authored by Shawn D. Keil

Since Specialization
Citations

This map shows the geographic impact of Shawn D. Keil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shawn D. Keil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shawn D. Keil more than expected).

Fields of papers citing papers by Shawn D. Keil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shawn D. Keil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shawn D. Keil. The network helps show where Shawn D. Keil may publish in the future.

Co-authorship network of co-authors of Shawn D. Keil

This figure shows the co-authorship network connecting the top 25 collaborators of Shawn D. Keil. A scholar is included among the top collaborators of Shawn D. Keil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shawn D. Keil. Shawn D. Keil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Keil, Shawn D., et al.. (2017). Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology.. PubMed. 15(4). 357–364. 36 indexed citations
3.
Andrew, P., Heather F. Pidcoke, Shawn D. Keil, et al.. (2016). Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro. Transfusion. 56(S1). S6–15. 28 indexed citations
4.
Faddy, Helen M., Daniel Watterson, Paul R. Young, et al.. (2016). Riboflavin and ultraviolet light: impact on dengue virus infectivity. Vox Sanguinis. 111(3). 235–241. 30 indexed citations
5.
Keil, Shawn D., et al.. (2015). Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination. Journal of Visualized Experiments. e52820–e52820. 16 indexed citations
6.
Keil, Shawn D., et al.. (2015). Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination. Journal of Visualized Experiments. 6 indexed citations
7.
Owusu‐Ofori, Shirley, Alex Owusu‐Ofori, Graham Freimanis, et al.. (2014). Treatment of Whole Blood With Riboflavin and UV Light. Shock. 44(Supplement 1). 33–38. 28 indexed citations
8.
Keil, Shawn D., Natia Saakadze, Richard A. Bowen, et al.. (2014). Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products. Transfusion. 55(4). 858–863. 14 indexed citations
9.
Tonnetti, Laura, et al.. (2014). Reduction of Leishmania donovani infectivity in whole blood using riboflavin and ultraviolet light. Transfusion. 55(2). 326–329. 25 indexed citations
10.
Keil, Shawn D., Patti Kiser, James J. Sullivan, et al.. (2013). Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfusion. 53(10). 2278–2286. 29 indexed citations
11.
Reddy, Heather L., et al.. (2013). Development of a riboflavin and ultraviolet light‐based device to treat whole blood. Transfusion. 53(S1). 29 indexed citations
12.
Tonnetti, Laura, et al.. (2012). Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood. Transfusion. 53(4). 860–867. 33 indexed citations
13.
Vanlandingham, Dana L., Shawn D. Keil, Kate McElroy Horne, et al.. (2012). Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology system. Transfusion. 53(2). 284–290. 45 indexed citations
14.
Tonnetti, Laura, et al.. (2011). Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood. Transfusion. 52(2). 409–416. 35 indexed citations
15.
Goodrich, Raymond P., Brian Custer, Shawn D. Keil, & Michael P. Busch. (2010). Defining “adequate” pathogen reduction performance for transfused blood components. Transfusion. 50(8). 1827–1837. 33 indexed citations
16.
17.
Asano, Hiroshi, Chih‐Yuan Lee, Karen Fox-Talbot, et al.. (2007). Treatment With Riboflavin and Ultraviolet Light Prevents Alloimmunization to Platelet Transfusions and Cardiac Transplants. Transplantation. 84(9). 1174–1182. 54 indexed citations
18.
Ruane, Patrick H., et al.. (2004). Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion. 44(6). 877–885. 289 indexed citations
20.
Keil, Shawn D., Patrick H. Ruane, Matthew S. Platz, et al.. (2004). Riboflavin and UV-Light Based Pathogen Reduction: Extent and Consequence of DNA Damage at the Molecular Level. Photochemistry and Photobiology. 80(1). 15–15. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026